
    
      If you are in the high risk group you will be assigned randomly (like tossing a coin) to
      receive either AmBisome or fluconazole. If you are in the low risk group, you will not
      receive any treatment. Both groups will be monitored for IFIs. The study will last for 100
      days following your liver transplant.
    
  